Flucytosine
NDC 40032-771, Flucytosine, capsule, from Novel Laboratories, Inc..
- Product NDC
- 40032-771
- Status
- Listed
- Labeler
- Novel Laboratories, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204652
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/40032-771 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FLUCYTOSINE250 mg/1
Pharmacologic classes
Nucleoside Analog Antifungal [EPC]; Nucleoside Analog [EXT]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 40032-771-01 | 40032077101 | 100 CAPSULE in 1 BOTTLE (40032-771-01) |
| 40032-771-03 | 40032077103 | 30 CAPSULE in 1 BOTTLE (40032-771-03) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ee98e0a9-c125-4b5c-ba4e-ca3c9a1f2b90
Use it
Look up 40032-771 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/40032-771 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 40032-771. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.